Hironori Niizeki Selected Research

Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)

12/2021	Role of Prostaglandin E-Major Urinary Metabolite Levels in Identifying the Phenotype of Pachydermoperiostosis.
9/2021	Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
9/2015	Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations.
5/2015	Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer.
1/2013	Prostaglandin E2 increase in pachydermoperiostosis without 15-hydroprostaglandin dehydrogenase mutations.
10/2012	Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hironori Niizeki Research Topics

Disease

6	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 12/2021 - 10/2012
4	Contact Dermatitis (Eczema, Contact) 08/2020 - 09/2002
2	Arthralgia (Joint Pain) 01/2021 - 04/2018
2	Erythema 08/2020 - 05/2005
2	Tuberous Sclerosis (Bourneville's Disease) 08/2020 - 01/2018
2	Pemphigus (Pemphigus Vulgaris) 06/2014 - 09/2007
2	Necrosis 05/2005 - 09/2002
1	Dermatitis 08/2020
1	Acne Vulgaris 08/2020
1	Pruritus (Itching) 08/2020
1	Arthritis (Polyarthritis) 04/2018
1	Pancreatitis 01/2018
1	Pathologic Constriction (Stenosis) 01/2018
1	Angiofibroma 01/2018
1	Ulcer 01/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2016
1	Fibrosis (Cirrhosis) 07/2015
1	Zlotogora-Ogur syndrome 07/2015
1	Edema (Dropsy) 07/2015
1	Hyperplasia 07/2015
1	Leg Ulcer 05/2015
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 04/2015
1	Epidermolysis bullosa with pyloric atresia 04/2015
1	Skin Diseases (Skin Disease) 06/2014
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 11/2013
1	Celiac Disease (Celiac Sprue) 01/2012
1	Allergic Rhinitis 10/2008
1	Urticaria (Hives) 10/2008
1	Exanthema (Rash) 05/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2008
1	Neoplasm Metastasis (Metastasis) 09/2007
1	Melanoma (Melanoma, Malignant) 09/2007
1	Bites and Stings (Sting) 11/2005
1	Carcinogenesis 11/2005
1	Drug Eruptions (Drug Eruption) 05/2005
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 05/2005
1	Tonsillitis 08/2004
1	Muscle Weakness 12/2003
1	Dermatomyositis (Dermatopolymyositis) 12/2003

Drug/Important Bio-Agent (IBA)

3	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2013
2	ProstaglandinsIBA 12/2021 - 10/2012
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 01/2018
2	trans-sodium crocetinate (crocetin)IBA 08/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2007
2	Desmoglein 1IBA 06/2014 - 09/2007
2	Desmoglein 3IBA 06/2014 - 09/2007
2	AutoantibodiesIBA 06/2014 - 09/2007
2	HaptensIBA 02/2009 - 09/2002
1	EicosanoidsIBA 09/2021
1	Pharmaceutical PreparationsIBA 08/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2018
1	BariumIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Filaggrin ProteinsIBA 01/2016
1	Organic Anion TransportersIBA 09/2015
1	NectinsIBA 07/2015
1	poliovirus receptorIBA 07/2015
1	MucinsIBA 07/2015
1	IntegrinsIBA 04/2015
1	NucleotidesIBA 04/2015
1	Immunoglobulin G (IgG)IBA 06/2014
1	ElementsIBA 06/2014
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2013
1	Oxidoreductases (Dehydrogenase)IBA 01/2013
1	Immunoglobulin A (IgA)IBA 01/2012
1	LipopolysaccharidesIBA 02/2009
1	Histamine Antagonists (Antihistamines)IBA 10/2008
1	Interleukin-10 (Interleukin 10)IBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 05/2008
1	ImmunosorbentsIBA 09/2007
1	EnzymesIBA 09/2007
1	Coloring Agents (Dyes)IBA 09/2007
1	AntibodiesIBA 09/2007
1	Connexin 26IBA 09/2007
1	AntigensIBA 11/2005
1	bucillamine (SA 96)IBA 05/2005
1	Macrophage Migration-Inhibitory FactorsIBA 08/2004
1	C-Reactive ProteinIBA 08/2004
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002

Therapy/Procedure

1	Capsule Endoscopes 01/2018
1	Therapeutics 06/2014
1	Stem Cell Transplantation 05/2008